Cyclic trinuclear diorganotin(IV) complexes - The first tin compounds bearing oximehydroxamate ligands: synthesis, structural characterization and high in vitro cytotoxicity

European Journal of Inorganic Chemistry

Volumn , Issue 25, 2009, Pages 3765-3769

  Gajewska, Malgorzata ^a   Luzyanin, Konstantin V ^a   Guedes Da Silva, M Fátima C ^a,b   Li, Qingshan ^c   Cui, Jingrong ^d   Pombeiro, Armando J L ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

Author keywords

Antitumor agents; N ligands; O ligands; Structure elucidation; Tin

Indexed keywords

CELL CULTURE; CHELATION; COMPLEXATION; HYDROGEN BONDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC SOLVENTS; SYNTHESIS (CHEMICAL); TIN COMPOUNDS; X RAY DIFFRACTION;

ANTITUMOUR AGENTS; DIORGANOTIN; IN-VITRO; N LIGANDS; N-LIGANDS; O LIGANDS; STRUCTURAL CHARACTERIZATION; STRUCTURE ELUCIDATION; TRINUCLEAR; VITRO CYTOTOXICITIES;

LIGANDS;

EID: 69049115110     PISSN: 14341948     EISSN: 10990682     Source Type: Journal    
DOI: 10.1002/ejic.200900388     Document Type: Article

References (44)

1. a) L. Pellerito, L. Nagy, Coord. Chem. Rev. 2002, 224, 111-150;
2. b) A. Chaudhary, M. Agarwal, R. V Singh, Appl, Organomet. Chem. 2006, 20, 295-303;
3. c) A. Chaudhary, R. V. Singh, Main Group Met. Chem. 2008, 31, 107-155.
4. a) A. J Crowe, "Antitumor Activity of Tin Compounds" in Metal Compounds in Cancer Therapy (Ed.: S. P. Fricker), Chapman & Hall, London, 1994, pp. 147-179;
5. b) M. Gielen, Coord. Chem. Rev. 1996, 151, 41-51;
6. 50Sn Tin Complexes and Their Therapeutic Potential, Wiley, New York, 2005;
7. d) M. Gielen, Appl. Organomet. Chem. 2002, 16, 481-494.
8. a) A. Penninks, M. Bol-Schoenmakers, W. Seinen, "Cellular Interactions of Organo-Tin Compounds in Relation to Their Antitumor Activity" in Tin-Based Antitumor Drugs (Ed.: M. Gielen), NATO ASI Series, Springer, Berlin, 1.990, pp. 169-190;
9. b) C. Pettinari, F. Marchetti, A. Cingolani, A. Lonrenzotti, E. Mundorff, M. Rossi, F. Caruso, Inorg. Chim. Acta 1997, 262, 33-46.
10. a) M. Gielen, M. Biesemans, R. Willem, Appl. Organomet. Chem, 2005, 19, 440;
11. b) M. Gielen, M. Biesemans, D. de Vos, R. Willem, J. Inorg. Biochem. 2000, 79, 139, and references cited therein;
12. c) J J. Bonire, S. P. Fricker, J. Inorg. Biochem. 2001, 83, 217;
13. d) M. Kemmer, M. Gielen, M. Biesemans, D. de Vos, R. Willem, Met.-Based. Drugs 1998, 5, 189;
14. e) J. Li, Y. Ma, R. Liu, J. Li, Appl. Organomet. Chem. 2001, 15, 227;
15. f) E. R. T. Tiekink, M. Gielen, À. Bouhdid, R. Willem, V. I. Bregadze, L. V. Ermanson, S. A. Glazun, Met.-Based. Drugs 1997, 4, 75;
16. g) M. Gielen, K. Handlir, M. Hollein, D. de Vos, Met.Based. Drugs 2000, 7, 233.
17. a) F. P. Pruchnik, M. Banbula, Z. Ciunik, H. Chojnacki, M. Latocha, B. Skop, T. Wilczok, A. Opolski, J. Wietrzyk, A. Nasulewicz, Eur. J. Inorg. Chem. 2002, 3214-3221;
18. b) F. P. Pruchnik, M. Banbula, Z. Ciunik, M. Latocha, B. Skop, T. Wilczok, Inorg. Chim. Acta 2003, 356, 62-68;
19. c) F. P. Pruchnik, M. Banbula, H. Chojnacki, M. Latocha, B. Skop, T. Wilczok, Appl. Organomet. Chem. 2002, 16, 587-592.
20. a) Q. Li, M. F. C. Guedes da Silva, A. J. L. Pombeiro, Chem. Eur. J. 2004, 10, 1456-1462;
21. b) Q. Li, M. F. C. Guedes da Silva, Z. Jinghua, A. J. L. Pombeiro, J. Organomet. Chem. 2004, 689, 4584-4591;
22. c) X. Shang, J. Wu, A. J. L. Pombeiro, Q. Li, Appl. Organomet. Chem. 2007, 21, 919-925.
23. X. Shang, J. Cui, J. Wu, A. J. L. Pombeiro, Q. Li, J. Inorg. Biochem. 2008, 102, 901-909.
24. a) T. Baul, C. Masharing, G. Ruisi, R. Jira'sko, M. Holcapek, D. De-Vos, D. Wolstenholme, A. Linden, J. Organomet. Chem. 2007, 692, 4849-4862;
25. b) E. Katsoulakou, M. Tiliakos, G. Papaefstathiou, A. Terzis, C. Raptopoulou, G. Geromichalos, K. Papazisis, R. Papi, A. Pantazaki, D. Kyriakidis, P. Cordopatis, E. Zoupa, J. Inorg. Biochem. 2008, 102, 1397-1405.
26. a) A. Dobosz, N. M. Dudarenko, I. O. Fritsky, T. Glowiak, A. Karaczyn, H. Kozlowski, T. Y. Silva, J. Swiatek-Kozlowska, J. Chem. Soc, Dalton Trans. 1.999, 743;
27. b) K. N. Raymond, Coord Chem. Rev. 1.990, 105, 135-153;
28. c) J. B. Summers, B. P. Gunn, H. Mazdiyasni, A. M. Goetze, P. R. Young, J. B. Bouska, R. D. Dyer, D. W. Brooks, G. W. Carter, J. Med. Chem. 1987, 30, 2121-2126.
29. P. J Smith (Ed.), Chemistry of Tin, Blackie, London, 1988.
30. a) A. Graisa, Y. Farina, E. Yousif, M. Kassem, ARPN J. Eng. Appl. Sci. 2008, 3, 47-50;
31. b) Y. Farina, A. Graisa, M. Kassem, E. Yousif, Eur. J. Sci. Res. 2008, 22, 602-607.
32. B. Kurzak, H. Kozlowski, E. Parkas, Coord. Chem. Rev. 1992, 114, 169-200.
33. K. V. Luzyanin, M. Galanski, V. Yu. Kukushkin, A. D. Garnovskii, A. J L. Pombeiro, Inorg. Chim. Acta 2008, 567, 1738-1743.
34. a) Th. P. Lockhart, W. F. Manders, Inorg. Chem. 1986, 25, 892-895;
35. b) J. Oter, J. Organomet. Chem. 1981, 221, 57-61.
36. a) J Holecek, A. Lycka, Inorg. Chim. Acta 1986, 118, L15-L16;
37. b) J Holecek, M. Nadvornik, K. Handlir, J. Organomet. Chem. 1986, 315, 299-308.
38. Bruker, APEX2 & SAINT. Bruker, AXS Inc., Madison, Wisconsin, USA, 2004.
39. G. M. Sheldrick, SHELXS-97, Program for Crystal Structure Determination, University of Göttingen, Göttingen, Germany, 1997.
40. G. M. Sheldrick, Acta Crystallogr., Sect. A 2008, 64, 112-122.
41. L. J Farrugia, J. Appl, Crystallogr. 1999, 32, 837-838.
42. A. L. Spek, Acta Crystallogr., Sect. C 1990, 46, C34.
43. a) F. Denizot, R. Lang, J. Immunol. Methods 1986, 89, 111-277;
44. b) P. Skehan, R. Storeng, D. Scudiero, A. Monks, J McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, J. Nat. Cancer Inst. 1990, 82, 1107-1112.